CD33 and acute myeloid leukemia: Although AdFITC-CAR T-cells and single Db-FM significantly reduced tumor cell infiltration in the BM (Fig. 8I), the combination of Db-FM proved to be the most effective in reducing AML cells and the most efficient in targeting the double-positive CD33+CD117+ subpopulation (Fig. 8I, J).